Literature DB >> 21708260

Protein kinase C mediates peroxynitrite toxicity to oligodendrocytes.

Shihe Li1, Wen Lin, Flaubert Tchantchou, Ruby Lai, Jie Wen, Yumin Zhang.   

Abstract

Peroxynitrite has been suggested to be the potent oxidant causing toxicity to neurons and oligodendrocytes (OLs). Our previous studies have illustrated that intracellular zinc liberation contributes to peroxynitrite toxicity to mature OLs. In this study, we further investigated the signaling pathways involved in this event and identified protein kinase C (PKC) as an important early signaling molecule. We found that a non-selective PKC inhibitor bisindolylmaleimide-1 blocked OL toxicity induced by a peroxynitrite generator SIN-1 and exogenous zinc. The protective effects were due to its inhibition on ERK1/2 phosphorylation and ROS generation. The same phenomenon was also observed in OLs following prolonged treatment with phorbol 12 myristate 13 acetate (PMA), which downregulates the conventional and the novel PKC isoforms (cPKCs and nPKCs). To determine the role of specific PKC isoforms, we found that a specific nPKC inhibitor rottlerin significantly reduced SIN-1- or zinc-induced toxicity, whereas Go6976, a cPKC inhibitor, reduced OL toxicity triggered by zinc, but not by SIN-1 at high concentrations. Rottlerin was more potent than Go6976 to attenuate ERK1/2 phosphorylation and ROS generation induced by SIN-1 or zinc. Surprisingly, zinc only induced phosphorylation of PKCθ, but not PKCδ. Knockdown of PKCθ using lentiviral shRNA attenuated SIN-1- or zinc-induced toxicity. These results suggest that PKCθ might be the major PKC isoform involved in peroxynitrite and zinc toxicity to mature OLs, and provide a rationale for development of specific inhibitors of PKCθ in the treatment of multiple sclerosis and other neurodegenerative diseases, in which peroxynitrite formation plays a pathogenic role. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21708260     DOI: 10.1016/j.mcn.2011.06.006

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  4 in total

1.  Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.

Authors:  Jie Wen; Prasanth S Ariyannur; Rachel Ribeiro; Mikiei Tanaka; John R Moffett; Batool F Kirmani; Aryan M A Namboodiri; Yumin Zhang
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-25       Impact factor: 4.147

2.  Propofol restores TRPV1 sensitivity via a TRPA1-, nitric oxide synthase-dependent activation of PKCε.

Authors:  Pritam Sinharoy; Hongyu Zhang; Sayantani Sinha; Bethany C Prudner; Ian N Bratz; Derek S Damron
Journal:  Pharmacol Res Perspect       Date:  2015-06-11

Review 3.  The Emerging Role of Zinc in the Pathogenesis of Multiple Sclerosis.

Authors:  Bo Young Choi; Jong Won Jung; Sang Won Suh
Journal:  Int J Mol Sci       Date:  2017-09-28       Impact factor: 5.923

4.  Establishment of an erythroid progenitor cell line capable of enucleation achieved with an inducible c-Myc vector.

Authors:  Steven Mayers; Pablo Diego Moço; Talha Maqbool; Pamuditha N Silva; Dawn M Kilkenny; Julie Audet
Journal:  BMC Biotechnol       Date:  2019-04-15       Impact factor: 2.563

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.